Back to Results
First PageMeta Content
Science / Clinical research / Design of experiments / Evaluation methods / Food and Drug Administration / FDA Special Protocol Assessment / Clinical trial / Ultrasound / Pharmacovigilance / Medicine / Pharmacology / Pharmaceutical sciences


ACUSPHERE INC. REACHES SPECIAL PROTOCOL ASSESSMENT AGREEMENT WITH FDA FOR IMAGIFY™ PHASE 3 PLACEBO-CONTROLLED TRIAL LEXINGTON, MASS., June 8, [removed]Acusphere, Inc. (ACUS.PK), a specialty pharmaceutical company, today
Add to Reading List

Document Date: 2011-10-26 19:37:10


Open Document

File Size: 78,72 KB

Share Result on Facebook
UPDATE